Suppr超能文献

定量聚合酶链反应评估细菌性阴道病的治疗反应及早产风险

Quantitative Polymerase Chain Reaction to Assess Response to Treatment of Bacterial Vaginosis and Risk of Preterm Birth.

作者信息

Abramovici Adi, Lobashevsky Elena, Cliver Suzanne P, Edwards Rodney K, Hauth John C, Biggio Joseph R

机构信息

Center for Women's Reproductive Health, University of Alabama at Birmingham, Birmingham, Alabama.

出版信息

Am J Perinatol. 2015 Oct;32(12):1119-25. doi: 10.1055/s-0035-1549294. Epub 2015 May 29.

Abstract

OBJECTIVE

The aim of this study was to determine whether quantitative polymerase chain reaction (qPCR) bacterial load measurement is a valid method to assess response to treatment of bacterial vaginosis and risk of preterm birth in pregnant women.

STUDY DESIGN

Secondary analysis by utilizing stored vaginal samples obtained during a previous randomized controlled trial studying the effect of antibiotics on preterm birth (PTB). All women had risk factors for PTB: (1) positive fetal fibronectin (n=146), (2) bacterial vaginosis (BV) and a prior PTB (n=43), or (3) BV and a prepregnancy weight<50 kg (n=54). Total and several individual BV-related bacteria loads were measured using qPCR for 16S rRNA. Loads were correlated with Nugent scores (Spearman correlation coefficients). Loads were compared pre- and posttreatment with Wilcoxon rank-sum test. Individual patient differences were examined with Wilcoxon signed-rank test.

RESULTS

A total of 243 paired vaginal samples were available for analysis: 123 antibiotics and 120 placebo. Groups did not differ by risk factors for PTB. For all samples, bacterial loads were correlated with Nugent score and each of its specific bacterial components (all p<0.01). Baseline total bacterial load did not differ by treatment group (p=0.87). Posttreatment total bacterial load was significantly lower in the antibiotics group than the placebo group (p<0.01). Individual patient total bacterial load decreased significantly posttreatment in the antibiotics group (p<0.01), but not in the placebo group (p=0.12). The rate of PTB did not differ between groups (p=0.24). PTB relative risks calculated for BV positive versus BV negative women and women with the highest quartile total and individual bacterial loads were not statistically significant.

CONCLUSION

qPCR correlates with Nugent score and demonstrates decreased bacterial load after antibiotic treatment. Therefore, it is a valid method of vaginal flora assessment in pregnant women who are at high risk for PTB.

摘要

目的

本研究旨在确定定量聚合酶链反应(qPCR)测量细菌载量是否是评估孕妇细菌性阴道病治疗反应及早产风险的有效方法。

研究设计

利用先前一项研究抗生素对早产(PTB)影响的随机对照试验期间采集并储存的阴道样本进行二次分析。所有女性均有PTB风险因素:(1)胎儿纤连蛋白阳性(n = 146),(2)细菌性阴道病(BV)且既往有PTB史(n = 43),或(3)BV且孕前体重<50 kg(n = 54)。使用针对16S rRNA的qPCR测量总的及几种与BV相关的个体细菌载量。将载量与 Nugent评分(Spearman相关系数)进行关联。使用Wilcoxon秩和检验比较治疗前后的载量。使用Wilcoxon符号秩检验检查个体患者差异。

结果

共有243对阴道样本可用于分析:123例使用抗生素,120例使用安慰剂。各治疗组在PTB风险因素方面无差异。对于所有样本,细菌载量与 Nugent评分及其每种特定细菌成分均相关(所有p<0.01)。治疗组间基线总细菌载量无差异(p = 0.87)。抗生素组治疗后的总细菌载量显著低于安慰剂组(p<0.01)。抗生素组个体患者治疗后的总细菌载量显著降低(p<0.01),而安慰剂组未降低(p = 0.12)。两组间PTB发生率无差异(p = 0.24)。BV阳性与BV阴性女性以及总细菌载量和个体细菌载量处于最高四分位数的女性的PTB相对风险无统计学意义。

结论

qPCR与 Nugent评分相关,并显示抗生素治疗后细菌载量降低。因此,它是评估PTB高危孕妇阴道菌群的有效方法。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验